{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:11:47Z","timestamp":1792498307592,"version":"4.5.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Thymic epithelial tumors (TETs) are malignancies arising from the epithelium of the thymic gland, rare but with relatively favorable prognosis. TETs have different pathological subtypes: thymomas and thymic carcinoma, and they show different clinical characteristics regarding prognosis, pathology, and molecular profiles, etc. Although some studies have investigated the pathogenesis of TETs, more molecular data is still needed to further understand the underlying mechanisms among different TETs subtypes and populations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, we performed targeted gene panel sequencing and whole transcriptome sequencing on the tumor tissues from 27 Chinese TET patients, including 24 thymomas (A, AB, and B subtypes) and 3 thymic squamous cell carcinomas. We analyzed the genetic variations and differentially expressed genes among multiple TET subtypes. Moreover, we compared our data with the published The Cancer Genome Atlas (TCGA) TET data on both the genetic and transcriptomic levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared with the TCGA TET genomic data, we found that <jats:italic>NF1<\/jats:italic> and <jats:italic>ATM<\/jats:italic> were the most frequently mutated genes (each with a frequency of 11%, 3\/27). These mutations were not mutually exclusive, since one B1 thymoma showed mutations of both genes. The <jats:italic>GTF2I<\/jats:italic> mutation was mainly enriched in subtype A and AB thymomas, consistent with the previous reports. RNA-seq results unveiled that the genes related to thymus development (<jats:italic>FGF7<\/jats:italic>, <jats:italic>FGF10<\/jats:italic> and <jats:italic>CLDN4<\/jats:italic>) were highly expressed in certain TET subtypes, implicating that the developmental process of thymus might be linked to the tumorigenesis of these subtypes. We found high expression of <jats:italic>CD274<\/jats:italic> (PD-L1) in B2 and B3 thymoma samples, and validated its expression using immunohistochemistry (IHC). Based on the expression profiles, we further established a machine learning model to predict the myasthenia gravis status of TET patients and achieved 90% sensitivity and 70.6% specificity in the testing cohort.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study provides the first genomic and transcriptomic analysis of a Chinese TET cohort. The high expression of genes involved in thymus developmental processes suggests the potential association between tumorigenesis of TETs and dysregulation of developmental pathways. The high expression of PD-L1 in B2 and B3 thymomas support the potential application of immunotherapy on certain thymoma subtypes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2021.647512","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T05:58:04Z","timestamp":1631080684000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Transcriptomic and Mutational Analysis Discovering Distinct Molecular Characteristics Among Chinese Thymic Epithelial Tumor Patients"],"prefix":"10.3389","volume":"11","author":[{"given":"Naixin","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongsheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieming","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181f1f62d","article-title":"Epidemiology of Thymoma and Associated Malignancies","volume":"5","author":"Engels","year":"2010","journal-title":"J Thorac Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2007.11.004","article-title":"Thymic Epithelial Tumours: A Population-Based Study of the Incidence, Diagnostic Procedures and Therapy","volume":"44","author":"de Jong","year":"2008","journal-title":"Eur J Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1097\/JTO.0000000000000154","article-title":"ITMIG Consensus Statement on the Use of the WHO Histological Classification of Thymoma and Thymic Carcinoma: Refined Definitions, Histological Criteria, and Reporting","volume":"9","author":"Marx","year":"2014","journal-title":"J Thorac Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/cmi.2010.74","article-title":"Thymoma and Autoimmunity","volume":"8","author":"Shelly","year":"2011","journal-title":"Cell Mol Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2012.08.002","article-title":"Molecular Aspects of Thymic Carcinoma","volume":"78","author":"Weissferdt","year":"2012","journal-title":"Lung Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ccell.2018.01.003","article-title":"The Integrated Genomic Landscape of Thymic Epithelial Tumors","volume":"33","author":"Radovich","year":"2018","journal-title":"Cancer Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-016-0144-8","article-title":"Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets","volume":"23","author":"Enkner","year":"2017","journal-title":"Pathol Oncol Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/srep07336","article-title":"Mutations of Epigenetic Regulatory Genes Are Common in Thymic Carcinomas","volume":"4","author":"Wang","year":"2014","journal-title":"Sci Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgx094","article-title":"The Genomic and Epigenomic Landscape in Thymic Carcinoma","volume":"38","author":"Saito","year":"2017","journal-title":"Carcinogenesis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2008.03.013","article-title":"Mutational Status of EGFR and KIT in Thymoma and Thymic Carcinoma","volume":"62","author":"Yoh","year":"2008","journal-title":"Lung Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2008.03.035","article-title":"Absence of Gene Mutations in KIT-Positive Thymic Epithelial Tumors","volume":"62","author":"Tsuchida","year":"2008","journal-title":"Lung Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181e96e30","article-title":"Expression and Mutational Status of C-Kit in Thymic Epithelial Tumors","volume":"5","author":"Petrini","year":"2010","journal-title":"J Thorac Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3016","article-title":"A Specific Missense Mutation in GTF2I Occurs at High Frequency in Thymic Epithelial Tumors","volume":"46","author":"Petrini","year":"2014","journal-title":"Nat Genet"},{"key":"B14","volume-title":"WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart","author":"Travis","year":"2015"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp698","article-title":"Fast and Accurate Long-Read Alignment With Burrows-Wheeler Transform","volume":"26","author":"Li","year":"2010","journal-title":"Bioinformatics"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/ng.806","article-title":"A Framework for Variation Discovery and Genotyping Using Next-Generation DNA Sequencing Data","volume":"43","author":"DePristo","year":"2011","journal-title":"Nat Genet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","article-title":"A Program for Annotating and Predicting the Effects of Single Nucleotide Polymorphisms, SnpEff: SNPs in the Genome of Drosophila Melanogaster Strain W1118; Iso-2; Iso-3","volume":"6","author":"Cingolani","year":"2012","journal-title":"Fly (Austin)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0134-3","article-title":"Blood-Based Tumor Mutational Burden as a Predictor of Clinical Benefit in Non-Small-Cell Lung Cancer Patients Treated With Atezolizumab","volume":"24","author":"Gandara","year":"2018","journal-title":"Nat Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: Ultrafast Universal RNA-Seq Aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: Accurate Transcript Quantification From RNA-Seq Data With or Without a Reference Genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinf"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: A Class Discovery Tool With Confidence Assessments and Item Tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku1003","article-title":"STRING V10: Protein-Protein Interaction Networks, Integrated Over the Tree of Life","volume":"43","author":"Szklarczyk","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated Estimation of Fold Change and Dispersion for RNA-Seq Data With Deseq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"27:1","DOI":"10.1145\/1961189.1961199","article-title":"LIBSVM: A Library for Support Vector Machines","volume":"2","author":"Chang","year":"2011","journal-title":"ACM Trans Intelligent Syst Technol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz972","article-title":"ClinVar: Improvements to Accessing Data","volume":"48","author":"Landrum","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e2442","DOI":"10.1038\/cddis.2016.346","article-title":"Increased Expression of EHF via Gene Amplification Contributes to the Activation of HER Family Signaling and Associates With Poor Survival in Gastric Cancer","volume":"7","author":"Shi","year":"2016","journal-title":"Cell Death Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)00317-4","article-title":"Gene Expression Profiling of ERBB Receptors and Ligands in Human Transitional Cell Carcinoma of the Bladder","volume":"175","author":"Amsellem-Ouazana","year":"2006","journal-title":"J Urol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11154","article-title":"Increased Expression of EHF Contributes to Thyroid Tumorigenesis Through Transcriptionally Regulating HER2 and HER3","volume":"7","author":"Lv","year":"2016","journal-title":"Oncotarget"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2013.04.012","article-title":"Oncogenic ERBB3 Mutations in Human Cancers","volume":"23","author":"Jaiswal","year":"2013","journal-title":"Cancer Cell"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20151780","article-title":"Identification of Embryonic Precursor Cells That Differentiate Into Thymic Epithelial Cells Expressing Autoimmune Regulator","volume":"213","author":"Akiyama","year":"2016","journal-title":"J Exp Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.10.011","article-title":"Medullary Thymic Epithelial Stem Cells Maintain a Functional Thymus to Ensure Lifelong Central T Cell Tolerance","volume":"41","author":"Sekai","year":"2014","journal-title":"Immunity"},{"key":"B32","doi-asserted-by":"publisher","first-page":"djv151","DOI":"10.1093\/jnci\/djv151","article-title":"E2F8 as a Novel Therapeutic Target for Lung Cancer","volume":"107","author":"Park","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8121","article-title":"Upregulation of E2F8 Promotes Cell Proliferation and Tumorigenicity in Breast Cancer by Modulating G1\/S Phase Transition","volume":"7","author":"Ye","year":"2016","journal-title":"Oncotarget"},{"key":"B34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/imr.12404","article-title":"Development and Developmental Potential of Cortical Thymic Epithelial Cells","volume":"271","author":"Ohigashi","year":"2016","journal-title":"Immunol Rev"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.12826","article-title":"Impact of PD-L1, Transforming Growth Factor-Beta Expression and Tumor-Infiltrating CD8(+) T Cells on Clinical Outcome of Patients With Advanced Thymic Epithelial Tumors","volume":"9","author":"Duan","year":"2018","journal-title":"Thorac Cancer"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.04.013","article-title":"Expression Patterns, Prognostic Value, and Intratumoral Heterogeneity of PD-L1 and PD-1 in Thymoma and Thymic Carcinoma","volume":"13","author":"Owen","year":"2018","journal-title":"J Thorac Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2018.08.037","article-title":"Clinicopathologic Features of Thymoma With the Expression of Programmed Death Ligand 1","volume":"107","author":"Hakiri","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-051718-013524","article-title":"Precision Management of Advanced Non-Small Cell Lung Cancer","volume":"71","author":"Yang","year":"2020","journal-title":"Annu Rev Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1177\/0300891620915788","article-title":"PD-L1 Expression Level in Different Thymoma Stages and Thymic Carcinoma: A Meta-Analysis","volume":"106","author":"Chen","year":"2020","journal-title":"Tumori"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-19-3703","article-title":"Comparison of PD-L1 Immunohistochemical Assays and the Significance of PD-L1 Expression in Thymoma","volume":"12","author":"Yokoyama","year":"2020","journal-title":"J Thorac Dis"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.647512\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T05:58:08Z","timestamp":1631080688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.647512\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,8]]},"references-count":40,"alternative-id":["10.3389\/fonc.2021.647512"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.647512","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,8]]},"article-number":"647512"}}